Latest Patent law Stories
BRUSSELS and MUNICH, February 26, 2015 /PRNewswire/ -- - Patent filings at the European Patent Office (EPO) reach all-time high in 2014
Patent broker IPOfferings’ Patent Value Quotient for Calendar 2014 shows an increase in the average price paid per issued U.S. Patent from 2013 to 2014, and that there are buyers for U.S.
Pressures on patent system challenge extraction of patent value. OTTAWA, Ontario, Feb. 24, 2015 /PRNewswire/ -- 2014 was a year in which patents were rarely out of the news.
-Annual Revenues Increased 27 Percent During 2014- INCLINE VILLAGE, Nev., Feb. 23, 2015 /PRNewswire/ -- PDL BioPharma, Inc.
Omar Rivero joins World Patent Marketing's war against patent troll scams as other Florida Democrats review a dismal year and plan for the future Miami Beach,
World Patent Marketing Continues To Educate Its Inventor Pool On The Dangers of Patent Troll Scams Miami Beach, Florida (PRWEB) February 21, 2015
World Patent Marketing Trade Show Division networks with fashion entrepreneurs Las Vegas, Nevada (PRWEB) February 22, 2015 World Patent Marketing sent
TweelX enables investors to purchase shares in royalty-generating music copyrights Nashville, TN (PRWEB) February 20, 2015 TweelX, a Nashville-based
'New Patent Will Also Significantly Extend the Life of Ameranth's patents' SAN DIEGO, Feb. 20, 2015 /PRNewswire/ -- Ameranth, Inc.
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.